High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.

Clarke JL, Pao W, Wu N, Miller VA, Lassman AB
J Neurooncol. 2010 99 (2): 283-6

PMID: 20146086 · PMCID: PMC3973736 · DOI:10.1007/s11060-010-0128-6

MeSH Terms (13)

Adenocarcinoma ErbB Receptors Erlotinib Hydrochloride Female Humans Lung Neoplasms Male Meningeal Neoplasms Middle Aged Mutation Protein Kinase Inhibitors Quinazolines Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links